Editor's letter

A happy new year to the readers of Pharma Technology Focus! 

In this year’s first issue, we take the opportunity to look back at major drug approvals and regulatory events to size up the biggest events of the past year. This issue’s Yearbook also features key themes in the healthcare sector to watch out for in the coming year. 

December 2023 marked the historic COP28 meeting where participants from nearly 200 countries agreed to phase out fossil fuels. Pharma, like other sectors, has been on a journey to reduce carbon emissions, with several companies having outlined their mission to reach net zero targets. This month’s cover story delves into these efforts, especially concerning Scope 3 emissions. 

Don’t miss stories on clinical trials, the future of cell and gene manufacturing, oncology drug development and more. 

All this and the latest news and analysis on the pharmaceutical and biotech industry.

Manasi Vaidya, editor